Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark.
Anne Høy Seemann VestergaardLars Holger EhlersMette Asbjoern NeergaardChristian Fynbo ChristiansenJan Brink ValentinSøren Paaske JohnsenPublished in: PharmacoEconomics - open (2023)
Within 1 year before death, total healthcare costs, mainly driven by hospital costs, were substantially lower for patients with non-cancer diseases compared with patients with cancer. Moreover, the costs of hospital-based specialist palliative care and hospice were minimal for patients with non-cancer diseases.